Jinhu Ma

418 total citations
19 papers, 318 citations indexed

About

Jinhu Ma is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jinhu Ma has authored 19 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Genetics. Recurrent topics in Jinhu Ma's work include Virus-based gene therapy research (7 papers), CAR-T cell therapy research (7 papers) and Cancer-related molecular mechanisms research (3 papers). Jinhu Ma is often cited by papers focused on Virus-based gene therapy research (7 papers), CAR-T cell therapy research (7 papers) and Cancer-related molecular mechanisms research (3 papers). Jinhu Ma collaborates with scholars based in China. Jinhu Ma's co-authors include Ping Cheng, Chao Su, Anliang Huang, Yanwei Chen, Bin Zhang, Gang Shi, Yan Zhang, Yuwei Zhang, Bin Shao and Liping Yang and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Acta Biomaterialia.

In The Last Decade

Jinhu Ma

18 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinhu Ma China 8 194 86 81 78 55 19 318
Eugene Froimchuk United States 9 329 1.7× 51 0.6× 67 0.8× 130 1.7× 30 0.5× 9 543
Laura Borodyansky United States 12 267 1.4× 72 0.8× 172 2.1× 84 1.1× 28 0.5× 28 470
Hajar Alemohammad Iran 9 194 1.0× 86 1.0× 127 1.6× 90 1.2× 29 0.5× 12 365
Marta Baro United States 11 218 1.1× 63 0.7× 130 1.6× 163 2.1× 30 0.5× 19 418
Basira Najafzadeh Iran 8 183 0.9× 81 0.9× 119 1.5× 75 1.0× 25 0.5× 11 342
Wenhao Shen China 14 274 1.4× 140 1.6× 64 0.8× 56 0.7× 100 1.8× 31 471
Paul Blezinger United States 7 310 1.6× 120 1.4× 64 0.8× 63 0.8× 37 0.7× 10 449
Wenguang Wang China 7 143 0.7× 81 0.9× 44 0.5× 107 1.4× 108 2.0× 14 319
Daniel F. Camacho United States 9 155 0.8× 80 0.9× 168 2.1× 85 1.1× 27 0.5× 11 396

Countries citing papers authored by Jinhu Ma

Since Specialization
Citations

This map shows the geographic impact of Jinhu Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinhu Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinhu Ma more than expected).

Fields of papers citing papers by Jinhu Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinhu Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinhu Ma. The network helps show where Jinhu Ma may publish in the future.

Co-authorship network of co-authors of Jinhu Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jinhu Ma. A scholar is included among the top collaborators of Jinhu Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinhu Ma. Jinhu Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Hua, Yamei Li, Chao Wang, et al.. (2025). Epigenetically targeting PRMT5 promotes antitumor immunity by inducing endogenous retroviruses expression and triggering viral mimicry response. Translational research. 281. 55–68. 1 indexed citations
2.
Zhao, Jing, et al.. (2023). Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity. Frontiers in Immunology. 14. 982180–982180. 4 indexed citations
3.
Zhang, Yong, Fuyi Cheng, Jinhu Ma, Gang Shi, & Hongxin Deng. (2023). Development of cancer-associated fibroblast-related gene signature for predicting the survival and immunotherapy response in lung adenocarcinoma. Aging. 15(11). 4986–5006. 2 indexed citations
4.
Zhang, Bin, et al.. (2022). In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity. Frontiers in Oncology. 12. 897561–897561. 10 indexed citations
5.
6.
Chen, Yanwei, et al.. (2021). Antifibrotic Therapy Augments the Antitumor Effects of Vesicular Stomatitis Virus Via Reprogramming Tumor Microenvironment. Human Gene Therapy. 33(5-6). 237–249. 8 indexed citations
7.
Ma, Jinhu, Chunxue Zhang, Gang Shi, et al.. (2021). High-dose VitC plus oncolytic adenoviruses enhance immunogenic tumor cell death and reprogram tumor immune microenvironment. Molecular Therapy. 30(2). 644–661. 21 indexed citations
8.
Shi, Gang, Yan Yu, Jia Xu, et al.. (2021). Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment. Molecular Therapy — Oncolytics. 23. 488–500. 7 indexed citations
9.
Ma, Jinhu, Chao Su, Yanwei Chen, et al.. (2021). Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis. Acta Biomaterialia. 135. 567–581. 151 indexed citations
10.
Tan, Hong Kee, et al.. (2021). Identification of human LDHC4 as a potential target for anticancer drug discovery. Acta Pharmaceutica Sinica B. 12(5). 2348–2357. 5 indexed citations
11.
Ma, Jinhu, et al.. (2020). The Effect of Residual Triton X-100 on Structural Stability and Infection Activity of Adenovirus Particles. Molecular Therapy — Methods & Clinical Development. 19. 35–46. 12 indexed citations
12.
Ma, Jinhu, Chao Su, Yanwei Chen, et al.. (2019). A novel method to purify adenovirus based on increasing salt concentrations in buffer. European Journal of Pharmaceutical Sciences. 141. 105090–105090. 7 indexed citations
13.
Huang, Anliang, Jinhu Ma, Liyan Huang, Fan Yang, & Ping Cheng. (2018). Mechanisms for enhanced antitumor immune responses induced by irradiated hepatocellular carcinoma cells engineered to express hepatitis�B virus X protein. Oncology Letters. 15(6). 8505–8515. 3 indexed citations
14.
Huang, Anliang, Danying Liao, Jinhu Ma, et al.. (2016). SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models. Oncology Reports. 36(6). 3283–3290. 7 indexed citations
15.
Ma, Jinhu, Liping Yang, Chao Su, et al.. (2016). Hepatitis B virus X protein (HBx)-induced abnormalities of nucleic acid metabolism revealed by 1H-NMR-based metabonomics. Scientific Reports. 6(1). 24430–24430. 44 indexed citations
16.
Huang, Lin, et al.. (2016). Characterization and Inhibitor Screening of Plateau Zokor Lactate Dehydrogenase C4. Applied Biochemistry and Biotechnology. 179(6). 927–937. 2 indexed citations
17.
18.
Ma, Jinhu. (2014). Efficacy of lentinan combined with NP regimen in treatment of patients with advanced nonsmall-cell lung cancer and its effect on immunologic function. 5 indexed citations
19.
Ma, Jinhu, et al.. (2014). Inhibitor screening of lactate dehydrogenase C4 from black-lipped pika in the Western Sichuan Plateau. Bioscience Biotechnology and Biochemistry. 78(4). 651–654.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugene Froimchuk Breakdown of academic impact, for papers by Laura Borodyansky Breakdown of academic impact, for papers by Hajar Alemohammad Breakdown of academic impact, for papers by Marta Baro Breakdown of academic impact, for papers by Basira Najafzadeh Breakdown of academic impact, for papers by Wenhao Shen Breakdown of academic impact, for papers by Paul Blezinger Breakdown of academic impact, for papers by Wenguang Wang Breakdown of academic impact, for papers by Daniel F. Camacho
Rankless by CCL
2026